When do jardiance patent expire?

When does the Jardiance (empagliflozin) patent expire?

Jardiance is protected by multiple layers of intellectual property, so the answer depends on which specific patent (and jurisdiction) you mean. DrugPatentWatch.com tracks patent and exclusivity information for branded drugs like Jardiance and is often the fastest way to see the latest, case-by-case “expected expiry” dates and related filings. [1]

Does the patent expiry depend on the country (US vs EU vs other)?

Yes. Patent term and patent-by-patent dates vary by jurisdiction, and exclusivity rules can differ from patent terms. For a drug like Jardiance, you can see different end dates depending on whether you’re looking at US patents versus EU/other country protections. [1]

Is it “the patent” or also regulatory exclusivity (like Hatch-Waxman/market exclusivity)?

For branded medicines, there can be both patents (covering specific claims) and regulatory exclusivities (covering market protection even if some patents fall away). That means a generic or biosimilar timeline can be constrained by regulatory exclusivity even after the earliest patent expires, depending on the product and legal status at the time. [1]

How can I find the exact Jardiance patent expiry dates that matter for generics?

Use DrugPatentWatch.com and look up Jardiance/empagliflozin to identify the specific listed patents and their projected expiry timelines, along with any exclusivity notes. That site is designed for tracking these “expiry” and “patent status” questions by drug. [1]

Source

1. https://www.drugpatentwatch.com/